Viracta Therapeutics News

Viracta Therapeutics | 8-K: Current report

May 14 16:40 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 9 16:41 ET

Viracta Therapeutics | DEFA14A: Others

Apr 26 16:28 ET

Viracta Therapeutics | DEF 14A: Definitive information statements

Apr 26 16:10 ET

Viracta Therapeutics | 8-K: Current report

Apr 9 16:35 ET

Viracta Therapeutics | 8-K: Current report

Mar 20 16:48 ET

Viracta Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 7 17:06 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 7 16:16 ET

Viracta Therapeutics | 8-K: Current report

Nov 17, 2023 17:30 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 9, 2023 08:30 ET

Viracta Therapeutics | 8-K: Current report

Oct 4, 2023 07:01 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 14, 2023 08:02 ET

Viracta Therapeutics | 8-K: Current report

Aug 7, 2023 07:36 ET

Viracta Therapeutics | 8-K: Current report

Jun 9, 2023 16:53 ET

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports First Quarter 2023 Financial Results and Provides Clinical Program Updates

May 8, 2023 16:23 ET

Viracta Therapeutics | 8-K/A: Current report (Amendment)

May 5, 2023 16:52 ET

Viracta Therapeutics | 8-K: Current report

May 2, 2023 16:33 ET

Viracta Therapeutics | DEFA14A: Others

Apr 27, 2023 16:03 ET

Viracta Therapeutics | DEF 14A: Definitive proxy statements

Apr 27, 2023 16:01 ET

Viracta Therapeutics | 8-K: Current report

Mar 31, 2023 16:31 ET